Advanced Biomed Inc. is a Nevada‑incorporated holding company specializing in innovative biomedical technologies for cancer detection and precision medicine. Operating through subsidiaries in Taiwan, Hong Kong, and Mainland China, the Company has developed a proprietary microfluidic platform that integrates semiconductor and biotechnology to enable advanced circulating tumor cell (CTC) detection, enrichment, and analysis. Its portfolio includes devices, biochips, and designed for cancer screening, diagnosis, treatment selection, and prognosis assessment, with regulatory clearances in progress in China and plans for future global expansion.